214 related articles for article (PubMed ID: 11045288)
1. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
Sezer S; Ozdemir N; Arat Z; Güz G; Sengül S; Akman B; Haberal A; Turan M; Haberal M
Adv Perit Dial; 2000; 16():177-81. PubMed ID: 11045288
[TBL] [Abstract][Full Text] [Related]
2. Polyglucose dialysis solution induces changes in blood chemistry.
Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M; Mariak I
Adv Perit Dial; 2001; 17():101-8. PubMed ID: 11510254
[TBL] [Abstract][Full Text] [Related]
3. Predictors of serum albumin level in patients receiving continuous ambulatory peritoneal dialysis.
Sezer S; Ozdemir FN; Akman B; Arat Z; Anaforoglu I; Haberal M
Adv Perit Dial; 2001; 17():210-4. PubMed ID: 11510278
[TBL] [Abstract][Full Text] [Related]
4. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M
Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
[TBL] [Abstract][Full Text] [Related]
5. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
Hakemi MS; Golbabaei M; Nassiri A; Kayedi M; Hosseini M; Atabak S; Ganji MR; Amini M; Saddadi F; Najafi I
Iran J Kidney Dis; 2010 Jan; 4(1):44-9. PubMed ID: 20081304
[TBL] [Abstract][Full Text] [Related]
6. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
[TBL] [Abstract][Full Text] [Related]
7. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
8. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
10. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
11. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
12. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
15. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.
Kalender B; Ozdemir AC; Koroglu G
Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695
[TBL] [Abstract][Full Text] [Related]
16. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
Marcovici O; Boner G; Rosenfeld JB
Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
[TBL] [Abstract][Full Text] [Related]
17. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation.
Hüting J; Alpert MA
Clin Cardiol; 1992 Mar; 15(3):190-6. PubMed ID: 1532353
[TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation and parathyroid hormone influence the cytosolic calcium levels of erythrocytes in peritoneal dialysis patients.
Sahin E; Goçmen AY; Gümüşlü S; Sahin M; Koçak H; Tuncer M
Clin Lab; 2011; 57(7-8):551-7. PubMed ID: 21888020
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.
Suzuki T; Kanno Y; Nakamoto H; Okada H; Sugahara S; Suzuki H
Adv Perit Dial; 2003; 19():148-54. PubMed ID: 14763052
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
